Filed under: drug development, Drug Discovery, Patient Safety, Pharmacogenomics | Leave a Comment »
How to improve R&D productivity: the pharmaceutical industry’s grand challenge
Posted on February 3, 2011 by Albin Paul
Chinese drug discovery market predicted to grow 23% per annum
Posted on November 17, 2010 by Albin Paul
China’s health and medical industry is advancing rapdily within genomics, combinatorial chemistry and high-throughput screening, China has been recognised as an important location to which drug discovery is being outsourced. The Chinese drug discovery market reached US$315.0 million in 2009 and is predicted to expand at a compound annual growth rate of 23% from 2009 to [...]
Filed under: clinical research, Clinical Trial, drug development, Drug Discovery | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | Leave a Comment »
Eli Lilly CIO Michael Heim says Lilly will increase use of cloud computing in clinical data management
Posted on November 17, 2010 by Albin Paul
Eli Lilly’s CIO Michael Heim says that the drug giant’s right to know where in the cloud its data resides, and to know the provider’s disaster recovery plans are chief issues that will drive the use of cloud computing in clinical data within drug discovery and development projects. An interview with Michael Heim is available [...]
Filed under: drug development, drug discoverry, Drug Discovery | Tagged: clinical data, cloud computing, Drug Development, drug discovery | Leave a Comment »
